Oklahoma’s medical cannabis producers and distributors must now obtain federal authorization. Registration with the DEAThis is a major regulatory change that has been triggered by the recent federal reclassification. The U.S. Department of Justice issued an order on April 28th 2026 rescheduling some marijuana under Schedule III of Controlled Substances Act. Oklahoma Bureau of Narcotics has confirmed in a recent report that all businesses participating in the medical marijuana program of Oklahoma must adhere to this federal mandate. KXII.
It is a significant step forward in aligning the state’s medical cannabis regulations with federal frameworks. This requirement is applicable to all manufacturers and distributors in Oklahoma who are involved with the medical cannabis supply chains. It impacts their compliance and operational obligations.
Oklahoma Operators must register under federal law
Medical cannabis companies licensed by state governments are affected directly by the U.S. Department of Justice’s recent decision to shift certain marijuana forms to Schedule III of Controlled Substances Act. The rescheduling of marijuana to Schedule III under the Controlled Substances Act offers a federal classification that is different, but it also introduces compliance requirements for all entities dealing with these substances.
Oklahoma Bureau of Narcotics clarifies that manufacturers and distributors who participate in Oklahoma’s Medical Marijuana Program must obtain DEA registration. The registration is a federal process that requires strict DEA rules.
Business previously licensed by the state will have to adjust to new federal regulations and be held accountable for federal compliance.
Compliance Timeline and Enforcement
Oklahoma Bureau of Narcotics outlined an exact timeline to facilitate transition. OBN announced that administrative actions against medical marijuana companies operating without DEA approval will be delayed until the first of January 2027.
Dates and key provisions that operators should be aware of include:
- Applications Window Businesses who submit their applications to register with the DEA within 60 days after publication on April 28th, 2026 may operate while their application awaits review. This provision is designed to protect proactive applicants from immediate business disruptions.
- Processing Commitment DEA Administrator is required to do everything possible to complete all applications within 6 months, if they are received in the initial 60 day period. This commitment demonstrates the agency’s intention to efficiently manage the influx anticipated of new registrations.
- Effective Date On January 1, 2027, the OBN will begin to take administrative actions against those who do not comply with federal DEA requirements.
Oklahoma’s medical cannabis business owners could face severe penalties if the federal DEA registration is not obtained. OBN indicated that a non-compliance with federal or state laws could lead to the possible revocation of an Oklahoma business’s registration. OBN states that, due to federal and Oklahoma state laws’ complexity, they cannot give legal advice on compliance. For businesses with questions specific to their obligations, it is recommended that they seek the advice of an attorney in regulatory compliance or controlled substances law.
Disclaimer: The article provided here is only for informative purposes and not intended to be a medical recommendation. Hemp Gazette is not a medical provider and does not offer diagnoses or treatment plans. Before making decisions about your health, or any condition that may affect it, always consult with a medical professional. The Therapeutic Goods Administration in Australia (TGA) has not evaluated any statements regarding the therapeutic use of cannabis or hemp-derived products. TGA regulates the access to medical cannabis in Australia.